Back to search
Still's Disease, Juvenile Onset
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Still's Disease, Juvenile Onset trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Still's Disease, Juvenile Onset trials you may qualify forThe study is a phase II trial designed to evaluate the clinical efficacy, safety, and tolerability of MAS825 in pediatric and adult participants with Still's di…
Background: Inflammatory conditions can cause symptoms like fevers, arthritis, and rash. Systemic juvenile idiopathic arthritis (sJIA) is one of these conditio…
The purpose of this study is to compare the efficacy and safety of firsekibart versus anakinra in patients with AOSD.
Background: Hemophagocytic lymphohistiocytosis (HLH) is a disease caused by disrupted immune function. People with HLH are prone to fevers and illnesses, which…
To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.
Adult Onset Still Disease (AOSD) and Systemic onset Juvenile Idiopathic Arthritis (SoJIA) are two rare multifactorial diseases associated with systemic inflamma…
This study aims to assess and characterize the treatment patterns, and long-term clinical outcomes and demographic characteristics of patients diagnosed with Fa…
This study was designed to evaluate the efficacy and safety of canakinumab administered subcutaneously every 4 weeks for at least 48 weeks in Japanese patients…
The purpose of this study is to assess the safety, tolerability and efficacy of emapalumab in children and adults with macrophage activation syndrome (sHLH/MAS)…